{"id":"https://openalex.org/W2602247476","doi":"https://doi.org/10.1200/jco.2013.31.15_suppl.e11615","title":"Pathologic complete response (pCR) to predict patients\u2019 survival in luminal breast cancer.","display_name":"Pathologic complete response (pCR) to predict patients\u2019 survival in luminal breast cancer.","publication_year":2013,"publication_date":"2013-05-20","ids":{"openalex":"https://openalex.org/W2602247476","doi":"https://doi.org/10.1200/jco.2013.31.15_suppl.e11615","mag":"2602247476"},"language":"en","primary_location":{"id":"doi:10.1200/jco.2013.31.15_suppl.e11615","doi":"https://doi.org/10.1200/jco.2013.31.15_suppl.e11615","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2013.31.15_suppl.e11615","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","is_traditional":false,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5057710694","display_name":"Qian Wang-Lopez","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210128870","display_name":"Centre Hospitalier Universitaire de Clermont-Ferrand","ror":"https://ror.org/02tcf7a68","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210128870"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Qian Wang-Lopez","raw_affiliation_strings":["Clinical Investigation Centre, CHU, Clermont-ferrand, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Clinical Investigation Centre, CHU, Clermont-ferrand, France","institution_ids":["https://openalex.org/I4210128870"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5084368181","display_name":"Fabrice Kwiatkowski","orcid":"https://orcid.org/0000-0002-4041-3999","observed_orcids":["https://orcid.org/0000-0002-4041-3999"]},"institutions":[{"id":"https://openalex.org/I4210124119","display_name":"Centre Jean Perrin","ror":"https://ror.org/02pwnhd33","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210124119"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Fabrice Kwiatkowski","raw_affiliation_strings":["Centre Jean Perrin, Service de statistique, Clermont-ferrand, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Centre Jean Perrin, Service de statistique, Clermont-ferrand, France","institution_ids":["https://openalex.org/I4210124119"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5029086962","display_name":"Catherine Abrial","orcid":"https://orcid.org/0000-0002-1759-9457","observed_orcids":["https://orcid.org/0000-0002-1759-9457"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Catherine Abrial","raw_affiliation_strings":["ERTICA, EA 4677, Clermont-Ferrand, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"ERTICA, EA 4677, Clermont-Ferrand, France","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5069540694","display_name":"Marie\u2010Ange Mouret\u2010Reynier","orcid":"https://orcid.org/0000-0001-6981-1678","observed_orcids":["https://orcid.org/0000-0001-6981-1678","https://orcid.org/0000-0001-5542-5813"]},"institutions":[{"id":"https://openalex.org/I4210124119","display_name":"Centre Jean Perrin","ror":"https://ror.org/02pwnhd33","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210124119"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Marie-Ange Mouret-Reynier","raw_affiliation_strings":["Centre Jean Perrin/ERTICa EA 4677, Clermont-Ferrand, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Centre Jean Perrin/ERTICa EA 4677, Clermont-Ferrand, France","institution_ids":["https://openalex.org/I4210124119"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5062351916","display_name":"Pascale Dubray\u2010Longeras","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210124119","display_name":"Centre Jean Perrin","ror":"https://ror.org/02pwnhd33","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210124119"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Pascale Dubray-Longeras","raw_affiliation_strings":["Centre Jean Perrin/ERTICa EA 4677, Clermont-Ferrand, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Centre Jean Perrin/ERTICa EA 4677, Clermont-Ferrand, France","institution_ids":["https://openalex.org/I4210124119"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5088999457","display_name":"Isabelle Van Praagh-Doreau","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210124119","display_name":"Centre Jean Perrin","ror":"https://ror.org/02pwnhd33","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210124119"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Isabelle Van Praagh-Doreau","raw_affiliation_strings":["Centre Jean Perrin, Clermont-Ferrand, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Centre Jean Perrin, Clermont-Ferrand, France","institution_ids":["https://openalex.org/I4210124119"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5054491719","display_name":"Nina Radosevic\u2010Robin","orcid":"https://orcid.org/0000-0002-1633-8730","observed_orcids":["https://orcid.org/0000-0002-1633-8730"]},"institutions":[{"id":"https://openalex.org/I4210124119","display_name":"Centre Jean Perrin","ror":"https://ror.org/02pwnhd33","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210124119"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Nina Radosevic-Robin","raw_affiliation_strings":["Centre Jean Perrin, Clermont-ferrand, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Centre Jean Perrin, Clermont-ferrand, France","institution_ids":["https://openalex.org/I4210124119"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5030260555","display_name":"Xavier Durando","orcid":"https://orcid.org/0000-0001-6035-3172","observed_orcids":["https://orcid.org/0000-0001-6035-3172","https://orcid.org/0000-0001-7971-9808"]},"institutions":[{"id":"https://openalex.org/I154526488","display_name":"Inserm","ror":"https://ror.org/02vjkv261","country_code":"FR","type":"government","lineage":["https://openalex.org/I154526488"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Xavier Durando","raw_affiliation_strings":["INSERM/UDA UMR990, Clermont-Ferrand, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"INSERM/UDA UMR990, Clermont-Ferrand, France","institution_ids":["https://openalex.org/I154526488"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5061340891","display_name":"Frederique Madeleine Penault-Llorca","orcid":"https://orcid.org/0000-0002-4279-5492","observed_orcids":["https://orcid.org/0000-0002-4279-5492"]},"institutions":[{"id":"https://openalex.org/I4210124119","display_name":"Centre Jean Perrin","ror":"https://ror.org/02pwnhd33","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210124119"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Frederique Penault-Llorca","raw_affiliation_strings":["Centre Jean Perrin/ERTICa EA 4677, Clermont-Ferrand, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Centre Jean Perrin/ERTICa EA 4677, Clermont-Ferrand, France","institution_ids":["https://openalex.org/I4210124119"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5072502548","display_name":"Philippe J. M. Chollet","orcid":"https://orcid.org/0000-0001-8457-7568","observed_orcids":["https://orcid.org/0000-0001-8457-7568"]},"institutions":[{"id":"https://openalex.org/I154526488","display_name":"Inserm","ror":"https://ror.org/02vjkv261","country_code":"FR","type":"government","lineage":["https://openalex.org/I154526488"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Philippe J. M. Chollet","raw_affiliation_strings":["INSERM/UDA UMR 990,, Clermont-Ferrand, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"INSERM/UDA UMR 990,, Clermont-Ferrand, France","institution_ids":["https://openalex.org/I154526488"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":3,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"31","issue":"15_suppl","first_page":"e11615","last_page":"e11615"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10183","display_name":"Breast Cancer Treatment Studies","score":1.0,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10183","display_name":"Breast Cancer Treatment Studies","score":1.0,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11134","display_name":"Breast Lesions and Carcinomas","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11885","display_name":"MRI in cancer diagnosis","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2741","display_name":"Radiology, Nuclear Medicine and Imaging"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/pathological-complete-response","display_name":"pathological complete response","score":0.9909999966621399},{"id":"https://openalex.org/keywords/luminal-breast-cancer","display_name":"luminal breast cancer","score":0.9980000257492065},{"id":"https://openalex.org/keywords/early-breast-cancer","display_name":"early breast cancer","score":0.6639999747276306},{"id":"https://openalex.org/keywords/neoadjuvant-chemotherapy","display_name":"neoadjuvant chemotherapy","score":0.8960000276565552},{"id":"https://openalex.org/keywords/anthracyclines","display_name":"anthracyclines","score":0.828000009059906},{"id":"https://openalex.org/keywords/docetaxel","display_name":"docetaxel","score":0.9480000138282776},{"id":"https://openalex.org/keywords/disease-free-survival","display_name":"disease-free survival","score":0.7229999899864197},{"id":"https://openalex.org/keywords/overall-survival","display_name":"overall survival","score":1.0},{"id":"https://openalex.org/keywords/prognostic-factors","display_name":"prognostic factors","score":0.7570000290870667},{"id":"https://openalex.org/keywords/breast-conserving-surgery","display_name":"breast-conserving surgery","score":0.7680000066757202},{"id":"https://openalex.org/keywords/her2-negative","display_name":"HER2-negative","score":0.6480000019073486},{"id":"https://openalex.org/keywords/hormone-receptor-positive","display_name":"hormone receptor-positive","score":0.7839999794960022}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9205499887466431},{"id":"https://openalex.org/C530470458","wikidata":"https://www.wikidata.org/wiki/Q128581","display_name":"Breast cancer","level":3,"score":0.7970890998840332},{"id":"https://openalex.org/C2776802502","wikidata":"https://www.wikidata.org/wiki/Q417589","display_name":"Anthracycline","level":4,"score":0.7165203094482422},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6440055966377258},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.5731075406074524},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.5325217843055725},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.4723198115825653},{"id":"https://openalex.org/C2779786085","wikidata":"https://www.wikidata.org/wiki/Q412616","display_name":"Trastuzumab","level":4,"score":0.4329086244106293},{"id":"https://openalex.org/C66339696","wikidata":"https://www.wikidata.org/wiki/Q6089397","display_name":"Log-rank test","level":3,"score":0.4226328730583191},{"id":"https://openalex.org/C10515644","wikidata":"https://www.wikidata.org/wiki/Q543310","display_name":"Survival analysis","level":2,"score":0.40970829129219055},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.3583657741546631}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1200/jco.2013.31.15_suppl.e11615","doi":"https://doi.org/10.1200/jco.2013.31.15_suppl.e11615","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2013.31.15_suppl.e11615","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.98580002784729,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2101740967","https://openalex.org/W2977683202","https://openalex.org/W4385485818","https://openalex.org/W2343203580","https://openalex.org/W2978922538","https://openalex.org/W2147415463","https://openalex.org/W2089678662","https://openalex.org/W2594070992","https://openalex.org/W2801045744","https://openalex.org/W2158036908"],"abstract_inverted_index":{"e11615":[0],"Background:":[1],"Gene":[2],"expression":[3],"studies":[4,320],"have":[5,126,295],"demonstrated":[6],"that":[7],"breast":[8,31,90,200,292,317],"cancer":[9,32,91],"can":[10],"be":[11,64],"divided":[12],"into":[13],"three":[14],"major":[15],"subgroups":[16],":":[17,77],"Luminal,":[18],"Human":[19],"Epidermal":[20],"Growth":[21],"Factor":[22],"Receptor-2":[23],"(HER2)":[24],"over-expression":[25],"and":[26,81,166,196,206,215,223,233,240,266,311],"Oestrogen":[27],"negative":[28,83],"(ER-).":[29],"Luminal":[30],"is":[33,47],"well":[34],"known":[35],"for":[36,290],"its":[37],"better":[38],"prognosis":[39],"compared":[40,268],"with":[41],"the":[42,131,253,270],"other":[43],"types.":[44],"Conversely,":[45],"response":[46,176,190],"less":[48],"effective":[49],"by":[50,94],"pCR":[51,61,210,244,258,276],"criteria":[52],"after":[53,191,282],"chemotherapy.":[54],"This":[55],"work":[56],"aimed":[57],"to":[58,74,103,130,213,269,323,328],"evaluate":[59],"if":[60],"could":[62],"still":[63],"considered":[65],"as":[66],"a":[67,188,257,261,279,283,316],"surrogate":[68,280],"marker":[69,281],"in":[70,98,107,139,155,264,308],"luminal":[71,88,291],"subgroup":[72],"according":[73,129,212],"immunohistochemical":[75],"classification":[76],"Hormonal":[78],"receptor":[79],"positive":[80],"HER2":[82],"(HR+HER2-).":[84],"Methods:":[85],"All":[86,243],"132":[87],"early":[89],"patients":[92,204,208,220,225,254,271,304,314],"treated":[93],"neo-adjuvant":[95],"chemotherapy":[96],"(NAC),":[97],"our":[99],"institution":[100],"from":[101],"2001":[102],"2007":[104],"were":[105,137],"included":[106],"this":[108],"study.":[109],"NAC":[110],"treatment":[111],"comprised":[112],"anthracycline":[113],"alone,":[114],"taxotere":[115],"alone":[116],"or":[117],"sequential":[118],"use":[119],"of":[120,135,145,182,247,287,303,313],"these":[121],"two":[122],"drugs.":[123],"Survival":[124],"curves":[125,136],"been":[127],"established":[128],"Kaplan-Meier\u2019s":[132],"method.":[133],"Comparison":[134],"performed":[138],"using":[140],"Log-rank":[141],"test.":[142],"The":[143],"median":[144,167],"follow-up":[146],"was":[147,161,171,178,238,277],"102":[148],"months":[149,289],"(range":[150,163,173],"59":[151],"\u2013":[152],"142":[153],"months)":[154],"October":[156],"2012.":[157],"Results:":[158],"Median":[159],"age":[160],"53.5":[162],"34\u201378)":[164],"years":[165],"initial":[168],"tumor":[169,310],"size":[170],"4cm":[172],"1-10).":[174],"Objective":[175],"rate":[177,237],"65%":[179],"(86":[180],"patients),":[181],"which":[183],"8%":[184],"(10":[185],"patients)":[186],"had":[187,259,305,315],"complete":[189],"6":[192],"courses.":[193],"One":[194],"hundred":[195],"six":[197],"(80%)":[198],"underwent":[199],"conservation":[201],"surgery.":[202],"Seven":[203],"(5%)":[205],"ten":[207],"achieved":[209,256],"(8%)":[211],"Chevallier":[214],"Satatloff\u2019s":[216],"classification,":[217,248],"respectively.":[218,242],"Twenty":[219],"did":[221,249,273],"relapse":[222],"18":[224],"died.":[226],"At":[227],"10":[228],"years,":[229],"Disease-free":[230],"survival":[231,235],"(DFS)":[232],"overall":[234],"(OS)":[236],"81%":[239],"84%,":[241],"patients,":[245],"regardless":[246],"not":[250,260,278],"relapse.":[251],"However,":[252,299],"who":[255,272,294],"significant":[262],"difference":[263],"DFS":[265],"OS":[267],"not.":[274],"Conclusions:":[275],"relatively":[284],"short":[285],"survey":[286],"100":[288],"cancers,":[293],"generally":[296],"late":[297],"relapses.":[298],"sixty":[300],"five":[301],"percent":[302],">50%":[306],"reduction":[307],"primary":[309],"80%":[312],"conservation.":[318],"Further":[319],"are":[321],"needed":[322],"identify":[324],"new":[325],"markers":[326],"able":[327],"predict":[329],"patients\u2019":[330],"survival.":[331]},"counts_by_year":[],"updated_date":"2026-10-06T10:28:23.643775","created_date":"2017-04-07T00:00:00"}